Schizophrenia trials in Spain

In Spain 20 Also abroad 473

20 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
Where
Barcelona, Madrid
Age
5 years to 17 years
People
400 worldwide
Run by
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See details and how to joinNCT07424404 · EU 2025-524062-16-00
No phaseNot yet taking people in Spain
Sleep Monitoring for Early Detection of Relapse in People With Schizophrenia or Bipolar Disorder Receiving Usual Treatment
Where
Logroño
Age
18 years to 60 years
People
30
Run by
International University of La Rioja
See details and how to joinNCT07921667
Phase 3Taking people
Evenamide in patients with treatment-resistant schizophrenia not responding to antipsychotics
Where
Barcelona, Oviedo, Sevilla, Vigo, Zamora
Age
18 years and over
People
135 worldwide
Run by
Newron Pharmaceuticals S.p.A.
See details and how to join2024-519836-18-00 · EU 2024-519836-18-00
Phase 2Taking people
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
Where
Albacete, Zamora, Zaragoza
Age
55 years and over
People
370 worldwide
Run by
Intra-Cellular Therapies, Inc.
See details and how to joinNCT06540833
Phase 3Taking people
Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
Where
Barcelona, Valladolid, Zamora
Age
18 years to 65 years
People
472 worldwide
Run by
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See details and how to joinNCT07686263 · EU 2025-523664-20-00
Phase 3Taking people
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Where
Lleida, Madrid, Majadahonda, Málaga, Salamanca, Sevilla, Valladolid, Zaragoza
Age
55 years to 90 years
People
406 worldwide
Run by
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See details and how to joinNCT06585787 · EU 2024-516363-92-00
Phase 3Taking people
Stratification and Treatment in Early Psychosis Study - ENHANCE
Where
Madrid, Seville
Age
16 years to 40 years
People
250 worldwide
Run by
University of Oxford
See details and how to joinNCT06778564 · EU 2025-521929-32-00
Phase 3Not yet taking people in Spain
Stratification and Treatment in Early Psychosis Study -ASSIST
Where
Madrid, Seville
Age
16 years to 50 years
People
250 worldwide
Run by
University of Oxford
See details and how to joinNCT07326124
Phase 3Not yet taking people in Spain
Stratification and Treatment in Early Psychosis Study - PROMOTE
Where
Bilbao, Madrid
Age
12 years to 35 years
People
586 worldwide
Run by
University of Oxford
See details and how to joinNCT07434973
Phase 2Taking people
A Clinical trial to evaluate the efficacy of vafidemstat in negative symptoms and cognitive impairment associated with schizophrenia. (EVOLUTION study)
Where
Alcorcón, Barcelona, Burgos, Elche, Madrid, Málaga, Oviedo, Pamplona, Sevilla, Torrejón de Ardoz, Vigo, Zamora
Age
18 years to 64 years
People
239 worldwide
Run by
Oryzon Genomics S.A.
See details and how to join2023-507372-42-00 · EU 2023-507372-42-00
Phase 4Taking people
Clinical Study Evaluating Pharmacogenomics-informed Pharmacotherapy Versus Dosing as Usual in Psychiatric Disorders
Where
Barcelona
Age
16 years to 70 years
People
2,500 worldwide
Run by
Parnassia Groep
See details and how to joinNCT05656469 · EU 2023-509680-25-00
No phaseTaking people
Social Isolation and Aging in Schizophrenia
Where
Madrid
Age
40 years to 70 years
People
650 worldwide
Run by
Icahn School of Medicine at Mount Sinai
See details and how to joinNCT07419321
Phase 4Taking people
Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology Analysis (SchizOMICS)
Where
Barcelona, Madrid, Mataro, Oviedo, Reus, Sabadell, Sevilla, Vigo, Vitoria
Age
Up to 64 years
People
244
Run by
Consorcio Centro De Investigacion Biomedica En Red
See details and how to joinNCT06060886 · EU 2024-516768-28-00
No phaseEnrolling by invitation
Understanding Mechanisms of Synaptic Degeneration Underlying Clinical Symptoms in Patients With MDs and NDs.
Where
Barcelona
Age
40 years and over
People
150
Run by
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
See details and how to joinNCT07234851
No phaseTaking people
Feeling Safe Study
Where
Barcelona
Age
18 years and over
People
35
Run by
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
See details and how to joinNCT07234708
Phase 4Taking people
The Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
Where
Barcelona
Age
18 years to 70 years
People
418 worldwide
Run by
Dr. Inge Winter
See details and how to joinNCT05958875 · EU 2023-506602-39-00
No phaseTaking people
Cognitive and Metacognitive Evaluation in VR-Based Avatar Therapy for Psychosis
Where
Barcelona
Age
18 years and over
People
30
Run by
Fundació Sant Joan de Déu
See details and how to joinNCT07091344
No phaseTaking people
Effectiveness of a Digital Platform in Engagement and Prognosis of Patients in an Early Intervention Pychosis Programme
Where
Sant Boi de Llobregat
Age
18 years to 40 years
People
128
Run by
Fundació Sant Joan de Déu
See details and how to joinNCT06556251
No phaseEnrolling by invitation
A Comprehensive Third-generation Intervention for People With Psychosis and Post-traumatic Stress Symptoms
Where
Pozuelo de Alarcón
Age
18 years to 65 years
People
100
Run by
Universidad Complutense de Madrid
See details and how to joinNCT05619822
Phase 2/3Taking people
Clinical trial to study the effect of an already authorized drug on other pathologies by administering it to people with a recent diagnosis of schizophrenia.
Where
Sevilla
Age
18 years to 64 years
People
37
Run by
Fundacion Para La Gestion De La Investigacion En Salud De Sevilla
See details and how to join2024-519778-38-00 · EU 2024-519778-38-00